@prefix this: <http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg> .
@prefix sub: <http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
   this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
   <http://purl.obolibrary.org/obo/DOID_9164> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_9164> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB00630> ;
    a rdf:Statement ;
    rdfs:label "\"FOSAMAX is contraindicated in patients with the following conditions:     Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia  [see  Warnings and Precautions (5.1)  Inability to stand or sit upright for at least 30 minutes  [see  Dosage and Administration (2.6)  Warnings and Precautions (5.1)  Do not administer FOSAMAX oral solution to patients at increased risk of aspiration.  Hypocalcemia  [see  Warnings and Precautions (5.2)  Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported  [see  Adverse Reactions (6.2)   Abnormalities of the esophagus which delay emptying such as stricture or achalasia ( 4  5.1 Inability to stand/sit upright for at least 30 minutes ( 2.6  4  5.1 Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. ( 4 Hypocalcemia ( 4  5.2 Hypersensitivity to any component of this product ( 4  6.2\"" ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:MedicalContraindication .
  <https://identifiers.org/drugbank:DB00630> bl:category bl:Drug .
}
sub:provenance {
   sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
   sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "IeCuS7sJs8ZrSUHIlcK5Bs6pGrLjszoFbikvxCH2+AEl3OdS96G1p96FX+BTVm3yIGY/xM+GfGA0PwVUKi25fvhXOfE5z9PrcedEfefiFCjKp+/YTZ+7dVIEcUB0ZQEp3r5GvWmQTm9kA5jjFziqYXmmlGQYEdZyl5yRDe6izkY=" ;
    npx:hasSignatureTarget this: .
  this: dct:created "2021-08-23T13:03:35.050+02:00"^^xsd:dateTime ;
    dct:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY> .
}